AIによる処方箋コンプライアンス監査ツール

家

AIプロンプト一覧

医療健康

処方箋審査アシスタント

${:__('collect %s',処方箋審査アシスタント)}$

医療健康

AI技術を活用し、薬剤師の調剤前審査を支援し、潜在的な薬物相互作用、用量異常、禁忌症を特定し、投薬の安全性と効率性を向上させます。

プロンプト内容

コピー

Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 Hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and a newly prescribed Ibuprofen 400mg tid. Analyze if this prescription contains drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the impact of NSAIDs on renal function and the combined risk with antiplatelet agents, and provide specific adjustment suggestions or warning information to ensure the safety and efficacy of the medication regimen.

コピー

シニア臨床薬剤師として、以下の電子処方箋のコンプライアンスを審査してください。患者は65歳の男性で、高血圧2級および軽度の腎機能不全（eGFR 45ml/min）と診断されています。現在の服用薬にはアムロジピン5mg qd、アスピリン100mg qd、そして新たに処方されたイブプロフェン400mg tidが含まれます。この処方に薬物-疾患の禁忌、薬物-薬物相互作用、または用量調整の必要性が含まれていないか分析し、特にNSAIDsの腎機能への影響と抗血小板薬との併用リスクに焦点を当て、投薬レジメンの安全性と有効性を確保するための具体的な調整提案または警告情報を提供してください。

コピー

共有リンクをコピーするにはクリック

コメント (0)

0/300

送信

おすすめ

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, potential contraindications, and dosage appropriateness, while flagging any risks according to the latest clinical guidelines, and finally provide a clear audit conclusion with adjustment recommendations.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, contraindication conflicts, and whether the dosage aligns with the patient's hepatic and renal function status. Identify any risk points based on the latest clinical guidelines, and finally provide adjustment suggestions or confirm safety, ensuring the output is concise and clinically actionable.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions to ensure patient safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, contraindication conflicts, and dosage appropriateness, especially for elderly patients or those with hepatic/renal impairment. Highlight any high-risk combinations and provide alternative solutions or medication warnings based on the latest clinical guidelines, ensuring the output is concise and directly supports the pharmacy review workflow.

処方箋審査アシスタント

Act as a senior clinical pharmacist reviewing prescriptions in an electronic health record system. Based on the patient's diagnosis, medical history, allergies, and concurrent medications, strictly verify the appropriateness of drug indications, dosages, routes, and durations against current clinical guidelines and package inserts. Focus on identifying potential drug-drug interactions, drug-disease contraindications, and necessary dose adjustments for special populations such as those with hepatic or renal impairment. If any risks or non-compliance issues are found, clearly specify the problem and provide evidence-based optimization suggestions or alternative regimens. Finally, output a structured, professional audit report to ensure medication safety and efficacy.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract drug names, dosages, routes, and frequencies, cross-referencing them with the patient's age, gender, renal/hepatic function, and medical history. Second, check for contraindicated combinations or severe adverse reaction risks using drug interaction databases, especially for vulnerable populations like the elderly or pregnant women. Finally, if dose exceedance, duplicate therapy, or drug-disease contraindications are found, clearly identify the risks and provide optimization suggestions aligned with the latest clinical guidelines to ensure safety, efficacy, and cost-effectiveness.